CC chemokine receptor 5 and renal-transplant survival

BACKGROUND About 1% of white populations are homozygous carriers of an allele of the gene for the CC chemokine receptor 5 (CCR5) with a 32 bp deletion (CCR5Delta32), which leads to an inactive receptor. During acute and chronic transplant rejection, ligands for CCR5 are upregulated, and the graft is infiltrated by CCR5-positive mononuclear cells. We therefore investigated the influence of CCR5Delta32 on renal-transplant survival. METHODS Genomic DNA from peripheral-blood leucocytes of 1227 renal-transplant recipients was screened by PCR for the presence of CCR5Delta32. Demographic and clinical data were extracted from hospital records. Complete follow-up data were available for 576 recipients of first renal transplants. Graft survival was analysed by Fisher's exact test and Kaplan-Meier plots compared with a log-rank test. FINDINGS PCR identified 21 patients homozygous for CCR5Delta32 (frequency 1.7%). One patient died with a functioning graft. Only one of the remaining patients lost transplant function during follow-up (median 7.2 years) compared with 78 of the 555 patients with a homozygous wild-type or heterozygous CCR5Delta32 genotype. Graft survival was significantly longer in the homozygous CCR5Delta32 group than in the control group (log-rank p=0.033; hazard ratio 0.367 [95% CI 0.157-0.859]). INTERPRETATION Patients homozygous for CCR5Delta32 show longer survival of renal transplants than those with other genotypes, suggesting a pathophysiological role for CCR5 in transplant loss. This receptor may be a useful target for the prevention of transplant loss.

[1]  K. Matsushima,et al.  International union of pharmacology. XXII. Nomenclature for chemokine receptors. , 2000, Pharmacological reviews.

[2]  B. Bennetts,et al.  HIV-1 infection in an individual homozygous for the CCR5 deletion allele , 1997, Nature Medicine.

[3]  C. Combadière,et al.  Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP‐1α, MIP‐1β, and RANTES , 1996, Journal of leukocyte biology.

[4]  W. Gong,et al.  Monocyte Chemotactic Protein-2 Activates CCR5 and Blocks CD4/CCR5-mediated HIV-1 Entry/Replication* , 1998, The Journal of Biological Chemistry.

[5]  A. Zlotnik,et al.  The biology of chemokines and their receptors. , 2000, Annual review of immunology.

[6]  Richard A Koup,et al.  Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.

[7]  A. Yussim,et al.  Acute cellular rejection of human renal tissue by adoptive transfer of allogeneic human peripheral blood mononuclear cells into chimeric rats: sequential gene expression of cytokines, chemokines and cytolytic effector molecules, and their regulation by CTLA-4-Ig. , 1999, International immunology.

[8]  Finn Sellebjerg,et al.  CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis , 2000, Journal of Neuroimmunology.

[9]  Marc Parmentier,et al.  Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.

[10]  W. Hancock,et al.  Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. , 2000, The Journal of clinical investigation.

[11]  S. Heidenreich,et al.  High rate of acute rejections in renal allograft recipients with thrombophilic risk factors. , 1998, Journal of the American Society of Nephrology : JASN.

[12]  G Vassart,et al.  Molecular cloning and functional expression of a new human CC-chemokine receptor gene. , 1996, Biochemistry.

[13]  C. Weber,et al.  Met‐RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  L. Peltonen,et al.  The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe. , 1998, Human molecular genetics.

[15]  M. Baggiolini.  Chemokines and leukocyte traffic , 1998, Nature.

[16]  J J Goedert,et al.  Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene , 1996, Science.

[17]  H. Marquart,et al.  CC chemokine receptor 5 polymorphism in rheumatoid arthritis. , 1998, The Journal of rheumatology.

[18]  M. Burdick,et al.  The Role of the CC Chemokine, RANTES, in Acute Lung Allograft Rejection1 , 2000, The Journal of Immunology.

[19]  Global distribution of the CCR5 gene 32-basepair deletion , 1997, Nature Genetics.

[20]  K. Nadeau,et al.  Sequential cytokine dynamics in chronic rejection of rat renal allografts: roles for cytokines RANTES and MCP-1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Hubbard,et al.  Association of CCR5 delta32 with reduced risk of asthma. , 1999, Lancet.

[22]  H. Ostrer,et al.  Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. , 1998, American journal of human genetics.

[23]  C. V. Jensen,et al.  CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis. , 2000, Journal of neuroimmunology.

[24]  A. Morley,et al.  β-chemokine expression and distribution in paraffin-embedded transplant renal biopsy sections: analysis by scanning laser confocal microscopy , 1998, Histochemistry and Cell Biology.

[25]  R. Hubbard,et al.  Association of CCR5 ▵32 with reduced risk of asthma , 1999, The Lancet.

[26]  R. Doms,et al.  CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. , 1999, Blood.

[27]  M. Fischereder,et al.  Early loss of renal transplants in patients with thrombophilia. , 1998, Transplantation.

[28]  N. Risch.  Searching for genetic determinants in the new millennium , 2000, Nature.

[29]  P. Gray,et al.  Molecular Cloning and Functional Characterization of a Novel Human CC Chemokine Receptor (CCR5) for RANTES, MIP-1β, and MIP-1α* , 1996, The Journal of Biological Chemistry.

[30]  M. Mack,et al.  Expression of the C-C chemokine receptor 5 in human kidney diseases. , 1999, Kidney international.

[31]  R. Doms,et al.  CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. , 1999 .

[32]  P. Huie,et al.  RANTES chemokine expression in cell-mediated transplant rejection of the kidney , 1994, The Lancet.